Bioorganic & Medicinal Chemistry Letters 2012-06-15

Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity

Virginie Suchaud, Fabrice Bailly, Cédric Lion, Enzo Tramontano, Francesca Esposito, Angela Corona, Frauke Christ, Zeger Debyser, Philippe Cotelle

文献索引:Bioorg. Med. Chem. Lett. 22(12) , 3988-92, (2012)

全文:HTML全文

摘要

We report herein the synthesis of a series of 3-hydroxyquinolin-2(1H)-one derivatives. Esters and amide groups were introduced at position 4 of the basis scaffold and some modulations of the benzenic moiety were performed. Most compounds presented selective inhibitory properties in the 10-20 μM range against HIV-1 reverse transcriptase associated ribonuclease H activity, without affecting the integrase and reverse transcriptase DNA polymerase activities. Unfortunately all tested compounds exhibited high cellular cytotoxicity in cell culture which limited their applications as antiviral agents.Copyright © 2012 Elsevier Ltd. All rights reserved.


相关化合物

  • 核糖核酸酶H

相关文献:

Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors.

2012-09-01

[Clin. Infect. Dis. 55(5) , 737-45, (2012)]

Metallobiochemistry of the magnesium ion. Characterization of the essential metal-binding site in Escherichia coli ribonuclease H.

1994-01-15

[Eur. J. Biochem. 219 , 253-60, (1994)]

更多文献...